Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
about
The junctional proteins cingulin and paracingulin modulate the expression of tight junction protein genes through GATA-4Claudin-14 regulates renal Ca⁺⁺ transport in response to CaSR signalling via a novel microRNA pathwayAlterations of the apical junctional complex and actin cytoskeleton and their role in colorectal cancer progressionParadigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesisTranscriptional regulators of claudins in epithelial tight junctionsNuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner.Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis.Interactions of CstF-64, CstF-77, and symplekin: implications on localisation and function.Claudin-4 deficiency results in urothelial hyperplasia and lethal hydronephrosis.Salmonella infection upregulates the leaky protein claudin-2 in intestinal epithelial cellsEnteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine.Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signalingLyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces trafficking to lysosomesMyofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells.Alterations in polyadenylation and its implications for endocrine disease.MicroRNA regulation in renal pathophysiologyCell transcriptional state alters genomic patterns of DNA double-strand break repair in human astrocytes.Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells.Claudin family of proteins and cancer: an overview.Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.Enterocytes' tight junctions: From molecules to diseasesRho GTPase signaling in the development of colorectal cancer.Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.Symplekin specifies mitotic fidelity by supporting microtubule dynamics.Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.Tumor necrosis factor-α induces a biphasic change in claudin-2 expression in tubular epithelial cells: role in barrier functions.Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q.Expression and distribution of symplekin regulates the assembly and function of the epithelial tight junction.
P2860
Q21133695-07FF125E-08B4-43F2-BFAB-D9D9BDBDF222Q24306467-2016ECC5-A80C-4964-A983-282465CD71D7Q26785540-69CC6F74-F15E-454C-BBAC-2DC5C408E39AQ26787279-2E2785DC-27AC-4297-858B-FA7C8356F640Q28261649-062FFFAE-0D98-452F-B027-2D0F987DE56EQ33812424-30D88278-928D-4BF7-B73E-1D964CD26013Q34457032-495E617D-EB4B-457A-BE76-01B16B6DAE0EQ34471019-5B1F1551-47D9-4816-B88A-964CB3B17ABEQ34533526-1E8EC35A-B455-45DF-B9F3-8FABA046B72EQ34625958-29A7673B-2C83-4E08-8B12-BA83990C1959Q35112967-5305A3C2-DBD6-4AD4-ABE8-A9C4F413A752Q35779157-2D5411BC-3B71-4297-8386-5B8C4B22966DQ35832402-B628DD80-F987-46E3-8A5B-54935BE0D0C0Q36452928-D9587726-8007-4395-9DFB-D7592DD64F16Q36676237-77423F21-767A-4EBD-BC5A-A87152FE12C3Q36824347-31B88AC6-E5FF-4BE8-A7E6-372116EA0C13Q37091758-B40E4E43-F988-4D86-87CF-E48BD5734990Q37580101-6A265966-BC36-4B6C-BB60-07BF316E8E10Q37665595-2C5565CA-937F-4F99-9389-04EF049A81C7Q37776656-A78EDA0A-DDD3-489C-AAB6-5EB493FC98D2Q37866083-241F020C-7691-4A32-BA2E-EF790C8E4328Q37970075-8A1A5A2B-3D33-45D0-BDF2-F85950AFAED6Q37998994-8D8E6E71-E2DB-43C8-A358-8A8C00D0F8F3Q39579734-CC945E0E-10AA-40F3-94E9-49D415DB3D00Q39631925-EF5ABB29-DD73-4110-A465-45053FB2DB6DQ39658518-7C9C6DE1-7BB8-438D-B386-DFE4A0B150D2Q40291645-C5F55026-7B8F-482B-A6D0-479AC2CF2273Q41460133-1F3B1029-E25C-4827-A83D-4B6074CADAAEQ47107706-AE6C976E-9C12-4B3D-9049-08D3234C42E0Q52620194-DBDF9CE4-EC55-4FF3-8553-CB9387426585
P2860
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@ast
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@en
type
label
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@ast
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@en
prefLabel
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@ast
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@en
P2093
P2860
P50
P356
P1476
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
@en
P2093
André Pélegrin
Caroline Bonnans
Dominique Joubert
Frédéric Hollande
Jean-François Bourgaux
Marina Papin
Michael Buchert
Véronique Garambois
P2860
P304
P356
10.1073/PNAS.0903747107
P407
P577
2010-01-25T00:00:00Z